NCT02754518View on ClinicalTrials.gov

Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Heart Failure
Interventions
DRUG

Entresto

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT02754518 - Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis | Biotech Hunter | Biotech Hunter